- AdventHealth
ORANGE CITY, Fla. – The AdventHealth East Florida Division has selected Dr. Andrew Weinfeld to serve as Chief Clinical Officer (CCO), effective July 8.
In this role, Weinfeld will be responsible for executing clinical and organizational strategy, improving clinical effectiveness and patient safety, and delivering exceptional patient experiences for the largest hospital system in the region.
Comprising seven hospitals with a total of 1,397 beds in Daytona Beach, DeLand, Orange City, New Smyrna Beach, Palm Coast, and Tavares, the AdventHealth East Florida Division employs over 11,000 team members, including nearly 400 physicians and advanced practitioners across 30 medical specialties in 70 practice locations.
The full-time CCO role is a critical position within the East Florida Division and Weinfeld will be instrumental in delivering consistency in clinical care across the division and promoting best practices.
"We are incredibly excited to have Dr. Weinfeld join our team," said Audrey Gregory, Ph.D., R.N., Executive Vice President and CEO for the AdventHealth East Florida Division. "His extensive experience and commitment to enhancing patient care make him the perfect fit for our organization. We are confident that his leadership will help us continue to deliver the exceptional, compassionate care that our community depends on."
For the first 13 years of his career, Weinfeld provided direct patient care as a board-certified general surgeon in the Denver-Boulder area. After taking on progressive leadership roles, he went on to serve as chief medical officer for several hospitals within the HCA system, most recently at HCA Presbyterian/St. Luke's Medical Center, a 680-bed hospital that shares a campus with Rocky Mountain Hospital for Children. Here, he demonstrated his ability to drive quality improvements, enhance patient outcomes, and streamline clinical operations.
His educational background includes a Bachelor of Science in Business Administration and International Business from the University of Colorado, a medical degree from the University of Rochester School of Medicine and Dentistry, a residency in general surgery from Ohio State University, and an Executive MBA in Health Administration from the University of Colorado-Denver.
He is a Fellow of the American College of Surgeons and a member of the American College of Healthcare Executives and the Medical Group Management Association.
Recent News
AdventHealth Cancer Institute Advances the Use of CAR T-Cell Therapy for Multiple Myeloma
CAR-T therapies have emerged as new treatment options for certain types of cancer through a one-time infusion that can lead to long-lasting remission.
AdventHealth Graduate Medical Education Program Celebrates 50 Years
Growing from a family practice residency to 24 accredited programs, AdventHealth’s Graduate Medical Education (GME) program celebrates 50 years.
New Clinical Trial Explores Digital Intervention for Apathy in Late-life Depression
Afflicting 30-50% of patients with late-life depression, apathy is a challenging psychiatric syndrome in older adulthood that can result in lack of motivation leading to poor self-care, physical...
AdventHealth Performs Central Florida’s First Liver Transplant for Unresectable Colorectal Liver Metastases
In June 2025, AdventHealth Abdominal Transplant Surgeon and Surgical Oncologist Ryan Day, MD, worked with a multidisciplinary team to perform Central Florida’s first liver transplant for unresectable...
AdventHealth Neuroscience Institute First in Florida to be Recognized as a GammaTile Center of Excellence
GammaTile is the first and only tile-based radiation therapy for the treatment of
operable brain tumors. The AdventHealth Neuroscience Institute began performing GammaTile procedures in 2021 and was...
An AdventHealth Collaboration Explores the Impact of Microgravity and Electrical Stimulation on Muscle Cell Health in Space
Using a muscle lab-on-chip model aboard the International Space Station (ISS), AdventHealth Translational Research Institute’s Dr. Paul Coen has been working with a multidisciplinary team from the...
AdventHealth Neuroscience Institute Among First in U.S. to Offer Phase IIa Clinical Trial of Troculeucel for Moderate Alzheimer’s Disease
While most clinical trials for Alzheimer’s disease have focused on patients with early or mild cognitive impairment, roughly 30% of those with Alzheimer’s have moderate stage disease for which there...
AdventHealth Translational Research Institute Selected as Clinical Site for National Study of Muscle, Mobility and Aging (SOMMA)
Under the leadership of Scientific Director and Principal Investigator Bret H. Goodpaster, PhD, the AdventHealth Translational Research Institute (TRI) is now enrolling men and women 70 years of age...
AdventHealth Neuroscience Institute Administers First Dose of Investigative NK Cell Therapy to Person with Alzheimer’s Disease
Under a single compassionate use Investigational New Drug (IND) authorization cleared by the U.S. Food and Drug Administration (FDA), the AdventHealth Neuroscience Institute worked with NKGen Biotech...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative Axillary Nodes Following Neoadjuvant Chemotherapy
Findings of the phase III, multicenter, randomized NSABP B-51-RTOG 1304 clinical trial were recently published in the New England Journal of Medicine with AdventHealth Cancer Institute’s Dr. Mamounas...
AdventHealth Study Exploring the Use of MR-Guided Focused Ultrasound (MRgFUS) to Disrupt the Blood-Brain Barrier for Treatment of Alzheimer’s Disease
Under the leadership of Dr. Valeria Baldivieso and Dr. Chandan Reddy, the AdventHealth Research Institute is the first and only site in Orlando offering the Exablate Blood-Brain Barrier (BBB)...
AdventHealth Research Institute Offers Phase II Clinical Trial of Etanercept for Treatment of Blast-Induced Tinnitus
Approximately 1 billion people throughout the world suffer from tinnitus (ringing in the ears), and it is the number one disability of those who serve in the U.S. military. The condition can disrupt...